Perkins Capital Management Inc M Dx Health Sa Transaction History

Perkins Capital Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 02, 2023	BUY	$2.69 - $3.86 $2,690 - $3,860	1,000 Added 0.25%	404,225 $1.13 Million
Q2 2023 Jul 21, 2023	SELL	$3.07 - $4.2 $16,885 - $23,100	-5,500 Reduced 1.35%	403,225 $1.38 Million
Q1 2023 May 09, 2023	BUY	$2.61 - $7.15 $845,431 - $2.32 Million	323,920 Added 381.96%	408,725 $1.32 Million
Q4 2022 Jan 26, 2023	SELL	$6.2 - $8.36 $18 - $25	-3 Reduced -0.0%	84,805 $561,000
Q3 2022 Oct 24, 2022	SELL	$6.1 - $8.84 $34,465 - $49,946	-5,650 Reduced 6.25%	84,808 $572,000
Q2 2022 Jul 29, 2022	BUY	$6.65 - $9.33 $3,045 - $4,273	458 Added 0.51%	90,458 $755,000
Q4 2021 Feb 10, 2022	BUY	$8.45 - $12.0 $760,499 - $1.08 Million	90,000 New	90,000 $857,000

9.5K

Ticker MDXH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 16,288,100
Market Cap $30.6M
Description
MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, the Netherlands, Belgium, Spain, Poland, Italy, rest of European Union, and internationally. Its novel prostate cancer genomic testing solutions are SelectMDx, a non-invasive urine test; and ConfirmMDx, an epigenetic test, which prov...

Get notified when there are updates to the investment portfolio of Perkins Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Perkins Capital Management Inc with notifications on news.